Mimedx (MDXG) Short term Debt (2011 - 2026)

Mimedx has disclosed Short term Debt across 10 years of filings, most recently posting $1.5 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $1.5 million, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (up 33.33% YoY), and the FY2025 annual result was $1.5 million, up 50.0% from the prior year.
• Short term Debt came in at $1.5 million for Q1 2026 at Mimedx, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $2.2 million in Q2 2024 to a low of $1.0 million in Q4 2023.
• The 4-year median for Short term Debt is $1.2 million (2025), against an average of $1.3 million.
• Peak annual rise in Short term Debt reached 50.0% in 2025, while the deepest fall reached 43.18% in 2025.
• Mimedx's Short term Debt stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then surged by 50.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• The last three Short term Debt figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.